10-63214620-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032776.3(JMJD1C):​c.1547C>G​(p.Thr516Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0353 in 1,613,868 control chromosomes in the GnomAD database, including 2,342 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T516A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.035 ( 286 hom., cov: 32)
Exomes 𝑓: 0.035 ( 2056 hom. )

Consequence

JMJD1C
NM_032776.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.31

Publications

14 publications found
Variant links:
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
JMJD1C Gene-Disease associations (from GenCC):
  • 22q11.2 deletion syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Illumina
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019951463).
BP6
Variant 10-63214620-G-C is Benign according to our data. Variant chr10-63214620-G-C is described in ClinVar as Benign. ClinVar VariationId is 460220.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.251 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JMJD1CNM_032776.3 linkc.1547C>G p.Thr516Ser missense_variant Exon 8 of 26 ENST00000399262.7 NP_116165.1 Q15652-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JMJD1CENST00000399262.7 linkc.1547C>G p.Thr516Ser missense_variant Exon 8 of 26 5 NM_032776.3 ENSP00000382204.2 Q15652-1
JMJD1CENST00000542921.5 linkc.1001C>G p.Thr334Ser missense_variant Exon 7 of 25 1 ENSP00000444682.1 Q15652-3
JMJD1CENST00000402544.5 linkn.1519C>G non_coding_transcript_exon_variant Exon 5 of 22 1

Frequencies

GnomAD3 genomes
AF:
0.0350
AC:
5324
AN:
152118
Hom.:
284
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00917
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0902
Gnomad ASJ
AF:
0.00980
Gnomad EAS
AF:
0.261
Gnomad SAS
AF:
0.0213
Gnomad FIN
AF:
0.0319
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0246
Gnomad OTH
AF:
0.0268
GnomAD2 exomes
AF:
0.0534
AC:
13295
AN:
248770
AF XY:
0.0483
show subpopulations
Gnomad AFR exome
AF:
0.00899
Gnomad AMR exome
AF:
0.115
Gnomad ASJ exome
AF:
0.0104
Gnomad EAS exome
AF:
0.270
Gnomad FIN exome
AF:
0.0324
Gnomad NFE exome
AF:
0.0248
Gnomad OTH exome
AF:
0.0397
GnomAD4 exome
AF:
0.0353
AC:
51615
AN:
1461632
Hom.:
2056
Cov.:
34
AF XY:
0.0340
AC XY:
24739
AN XY:
727140
show subpopulations
African (AFR)
AF:
0.00636
AC:
213
AN:
33476
American (AMR)
AF:
0.112
AC:
5000
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00922
AC:
241
AN:
26132
East Asian (EAS)
AF:
0.227
AC:
9000
AN:
39676
South Asian (SAS)
AF:
0.0167
AC:
1442
AN:
86250
European-Finnish (FIN)
AF:
0.0327
AC:
1744
AN:
53396
Middle Eastern (MID)
AF:
0.00572
AC:
33
AN:
5766
European-Non Finnish (NFE)
AF:
0.0282
AC:
31405
AN:
1111832
Other (OTH)
AF:
0.0420
AC:
2537
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
2719
5437
8156
10874
13593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1402
2804
4206
5608
7010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0350
AC:
5327
AN:
152236
Hom.:
286
Cov.:
32
AF XY:
0.0375
AC XY:
2792
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.00914
AC:
380
AN:
41562
American (AMR)
AF:
0.0900
AC:
1375
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00980
AC:
34
AN:
3470
East Asian (EAS)
AF:
0.262
AC:
1356
AN:
5172
South Asian (SAS)
AF:
0.0215
AC:
104
AN:
4826
European-Finnish (FIN)
AF:
0.0319
AC:
338
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0246
AC:
1671
AN:
68018
Other (OTH)
AF:
0.0284
AC:
60
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
239
479
718
958
1197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0243
Hom.:
37
Bravo
AF:
0.0395
TwinsUK
AF:
0.0294
AC:
109
ALSPAC
AF:
0.0265
AC:
102
ESP6500AA
AF:
0.00924
AC:
34
ESP6500EA
AF:
0.0264
AC:
215
ExAC
AF:
0.0471
AC:
5690
Asia WGS
AF:
0.120
AC:
414
AN:
3478
EpiCase
AF:
0.0214
EpiControl
AF:
0.0220

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 31, 2022
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

JMJD1C-related disorder Benign:1
Mar 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Early myoclonic encephalopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
14
DANN
Benign
0.89
DEOGEN2
Benign
0.0054
.;T;.
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.30
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.50
T;T;T
MetaRNN
Benign
0.0020
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.90
.;L;.
PhyloP100
1.3
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.19
.;N;N
REVEL
Benign
0.11
Sift
Benign
0.24
.;T;T
Sift4G
Benign
0.86
.;T;T
Polyphen
0.0020
.;B;.
Vest4
0.019, 0.034
MutPred
0.11
.;Gain of phosphorylation at T513 (P = 0.1277);.;
MPC
0.060
ClinPred
0.016
T
GERP RS
4.1
Varity_R
0.033
gMVP
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41274074; hg19: chr10-64974380; COSMIC: COSV67859351; COSMIC: COSV67859351; API